A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control

GnRH antagonist and GnRH agonist are widely used as androgen deprivation therapy for metastatic prostate cancer. A previous report demonstrated that patients with PSA levels of >20 ng/mL using GnRH antagonists showed favorable outcomes in comparison to those using GnRH agonists. An 82-year...

Full description

Bibliographic Details
Published in:	Case Reports in Oncology
Main Authors:	Rumiko Sugimura, Takashi Kawahara, Yasuhide Miyoshi, Masahiro Yao, Sawako Chiba, Hiroji Uemura
Format:	Article
Language:	English
Published:	Karger Publishers 2019-09-01
Subjects:	Degarelix GnRH antagonist CRPC
Online Access:	https://www.karger.com/Article/FullText/502859

Similar Items

Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy
by: Shikha Patel, et al.
Published: (2024-12-01)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2013-12-01)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
by: Robab Davar, et al.
Published: (2010-09-01)

Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01)

GnRH Antagonist Protocol Versus GnRH Agonist Long Protocol: A Retrospective Cohort Study on Clinical Outcomes and Maternal-Neonatal Safety
by: Jieru Zhu, et al.
Published: (2022-06-01)

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
by: Shan Liu, et al.
Published: (2021-07-01)

GnRH antagonist protocol versus long-acting GnRH agonist protocol on pregnancy outcomes in IVF/ICSI: a retrospective cohort study
by: Panpan Zhao, et al.
Published: (2025-12-01)

Efficacy and safety of degarelix in patients with prostate cancer: Results from a phase III study in China
by: Yinghao Sun, et al.
Published: (2020-07-01)

Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
by: Dan Zhang, et al.
Published: (2018-12-01)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
by: Madelaine J. Cho-Clark, et al.
Published: (2023-04-01)

GnRH Induces ERK-Dependent Bleb Formation in Gonadotrope Cells, Involving Recruitment of Members of a GnRH Receptor-Associated Signalosome to the Blebs
by: Liat Rahamim-Ben Navi, et al.
Published: (2017-06-01)

Micro-dose flare-up gonadotrophin-releasing hormone (GnRH) agonist vs. flexible gonadotrophin-releasing hormone (GnRH) antagonist protocol in patient with poor ovarian reserve
by: Zakia Mahdy Ibrahim, et al.
Published: (2011-12-01)

An Individualized Recommendation for Controlled Ovary Stimulation Protocol in Women Who Received the GnRH Agonist Long-Acting Protocol or the GnRH Antagonist Protocol: A Retrospective Cohort Study
by: Ming-Xing Chen, et al.
Published: (2022-07-01)

Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study
by: Juan Gui, et al.
Published: (2022-12-01)

Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT
by: Ensieh Shahrokh Tehrani Nejad, et al.
Published: (2018-08-01)

Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol
by: Dan Zhang, et al.
Published: (2021-07-01)

Uso de antagonista de GnRH (cetrorelix) em dose única para evitar ovulações prematuras em ciclos de fertilização assistida Single dose of GnRH antagonist (cetrorelix) to avoid premature ovulation in assisted fertilization cycles
by: Pedro Luís Rosan, et al.
Published: (2003-09-01)

Different dendritic domains of the GnRH neuron underlie the pulse and surge modes of GnRH secretion in female mice
by: Li Wang, et al.
Published: (2020-07-01)

A comparative analysis of progestin-primed ovarian stimulation versus GnRH antagonists protocols pertaining to stimulation parameters and embryological outcomes in patients with endometrioma
by: Fazilet Kubra Boynukalin, et al.
Published: (2025-07-01)

Presurgical treatment of uterine myomas with the GnRH-antagonist relugolix in combination therapy: an observational study
by: Ludovico Muzii, et al.
Published: (2024-09-01)

Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer
by: Shang-Yu Huang, et al.
Published: (2011-12-01)

Effectiveness and safety of GnRH antagonist originator and generic in real-world clinical practice: a retrospective cohort study
by: Mingzhu Cao, et al.
Published: (2024-06-01)

Effect of CD14/TLR4 antagonist on GnRH/LH secretion in ewe during central inflammation induced by intracerebroventricular administration of LPS
by: Karolina Haziak, et al.
Published: (2018-07-01)

GnRH Vaccine Could Suppress Serum Testosterone in Stallion Mules
by: Siriporn Khumsap, et al.
Published: (2024-06-01)

GnRH pulse generator activity in mouse models of polycystic ovary syndrome
by: Ziyue Zhou, et al.
Published: (2025-01-01)

Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis
by: Li Gu, et al.
Published: (2023-03-01)

IMMUNO-CASTRATION BY IMMUNIZATION WITH GnRH IN BLACK BENGAL BUCKS (CAPRA HIRCUS)
by: A.K. Mandal, et al.
Published: (2019-06-01)

Effects of gonadotropin-releasing hormone antagonist (GnRH-ant) cessation on trigger day in a GnRH-ant protocol: a meta-analysis
by: Xueying Li, et al.
Published: (2025-12-01)

Multi-dimensional oscillatory activity of mouse GnRH neurons in vivo
by: Su Young Han, et al.
Published: (2025-01-01)

GnRH-immunocastration: an alternative method for male animal surgical castration
by: Chun Wang, et al.
Published: (2023-10-01)

A prediction model for high ovarian response in the GnRH antagonist protocol
by: Yilin Jiang, et al.
Published: (2023-11-01)

Editorial: GnRH system contribution in cancer regulation and clinical treatment
by: Euclides Avila, et al.
Published: (2024-02-01)

The GnRH Pulse Generator
by: Pasha Grachev, et al.
Published: (2016-12-01)

Retrospective Analysis of Patients With Prostate Cancer Initiating GnRH Agonists/Antagonists Therapy Using a German Claims Database: Epidemiological and Patient Outcomes
by: Marie C. Hupe, et al.
Published: (2018-11-01)

Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol
by: Qijun Xie, et al.
Published: (2024-03-01)

Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval
by: Tzu-Ching Kao, et al.
Published: (2023-01-01)

Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study
by: Tien K. Le, et al.
Published: (2024-03-01)